Webinarul „Introduction to In Vitro Permeation Testing (IVPT): Strengths and Weaknesses” va avea loc joi, 7 aprilie 2022, cu sprijinul Teledyne Hanson Research.
Participarea la prezentarea în limba engleză urmată de o sesiune interactivă de întrebări și răspunsuri este gratuită dar este necesară înregistrarea. Subiectele webinarului și opțiunile de înregistrare sunt următoarele:
| Europe
15:00 / 3 PM EEST |
The Americas
21:00 / 9 PM EEST |
Asia/PacRim
4:00 / 4:00 AM EEST, April 8 |
| REGISTER | REGISTER | REGISTER |
The webinar is going to feature an introduction and critical study of in vitro permeation testing (IVPT) as it applies to in vitro skin penetration studies, and information on related new U.S. Food and Drug Administration guidance.
Speakers:
- Clive Roper, director of Roper Toxicology Consulting Ltd
- Frank Toner, associate director of In Vitro Dermal Services at Charles River Laboratories
The presentation will include vital information on draft guidance the FDA Office of Generics has provided, based on Acyclovir, to generate bioequivalence data without the use of clinical trials.
Presentation:
- What is IVPT?
- Why Perform IVPT?
- IVPT: The Five Steps
- Analytical method development
- Analytical method validation
- IVPT method development
- IVPT pilot
- IVPT pivotal
Following the presentation, you’ll have a valuable and unique opportunity to gain expert answers to your questions specific to IVPT in your lab. Teledyne Hanson representative Bruna Lousada also will offer information on the company’s IVPT-related instruments, products and services.
